India Vitamin B1 Market to grow at a steady rate During the Forecast Period
Growing awareness pertaining
to health among the population is expected to drive the growth of India vitamin
B1 market.
According
to TechSci Research report, “India Vitamin B1 Market By Product Type
(Thiamine Nitrate Type, Thiamine Hydrochloride Type, Others), By Source
(In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule,
Injectable Solution), By Dosage Strength (50mg, 100mg, 250mg), By Distribution
Channel (Online v/s Offline), By Application (Beriberi, Wernicke's
Encephalopathy Syndrome, Delirium, Others), By End User (Adult v/s Pediatric),
By Company, By Region, Forecast & Opportunities, FY2026”, the India vitamin B1 market is expected to grow at a steady
rate during the forecast period on account of the growing use of vitamin B1 in
treating various disease conditions such as Wernicke's Encephalopathy Syndrome,
Delirium, Korsakoff’s Syndrome, among others. Additionally, vitamin B1 is also
used as a feed supplement, thereby positively influencing the market growth
through FY2026. Besides, supportive policies and schemes such as the
establishment of bulk drug parks scheme and production linked incentive scheme
are further expected to create lucrative opportunities for the market growth
over the next few years. Government of India recently announced a production
linked incentive scheme worth 6,940 crores. This scheme is announced to boost
the bulk drug manufacturing in the country and reducing dependence on imports.
As a part of this scheme government identified 53APIs which are being imported
in the country from China. These APIs will now be manufactured in India and
financial support is being provided by the government for the set up of new
manufacturing facilities in the country which can manufacture these APIs. This
will help India in becoming self sufficient and reduce the dependency on
imports from China amidst Indo-China border tensions and COVID-19 pandemic. Also,
the status of the local manufacturing companies will be improved as a part of
this scheme. Another scheme, promoting the establishment of bulk drug parks in
different parts of country wherein the government will be providing 70% of
common infrastructural costs and 90% of the costs in case the facilities are
being established in hilly regions such as North-Eastern states, Himachal
Pradesh, Uttarakhand, among others was announced. The total amount sanctioned
for this scheme is 3,000 crores. However, side-effects such as nausea,
weakness, itching, warmth, skin discoloration, among others due to the consumption
of vitamin B1 can hamper the market growth over the next few years.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" India
vitamin B1 market "
https://www.techsciresearch.com/report/india-vitamin-b1-market/5140.html
The India vitamin B1 market is segmented based on product type, source, form,
dosage strength, distribution channel, application, end user, company and
region. Based on form, the market can be fragmented into tablet, capsule and injectable
solution. The tablets segment is expected to dominate the market since a single
tablet can accommodate a higher dose of API compared to a capsule. Also,
tablets having variable delivery of medication such as quick release, delayed
release and extended release are available. While capsules are fast acting and
have higher drug absorption. This in turn is expected to increase the demand
for capsules. Based on distribution channel, the market can be bifurcated into
online and offline. The offline segment is expected to dominate the market on
account of the well established network of drug stores and pharmacies in the country
where thiamine is available both as a prescription drug and as an over the
counter medication.
Meteoric Biopharmaceuticals Pvt. Ltd., Alpspure Lifesciences Private
Limited, GlaxoSmithKline Pharmaceuticals Ltd, DSM Nutritional Products India
Pvt. Ltd., Crystal Pharma, Qualitek Pharma Pvt. Ltd., Biophore India
Pharmaceuticals Private Limited, Prachi Pharmaceuticals Pvt. Ltd., Helichem
Laboratories Pvt Ltd, Otto Chemie Pvt Ltd and others are some of the leading
players operating in India vitamin B1 market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5140
Customers can also
request for 10% free customization on this report.
“India vitamin B1 market is expected to
witness growth during the forecast period on account of the growing demand for
the vitamin B1 supplements as an over the counter drug medication.
Additionally, growing demand for thiamine in preventing the complications in the
nervous system, brain muscles, heart, stomach & intestine, among others is
further expected to spur the market growth over the next few years.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Vitamin B1 Market By Product Type (Thiamine
Nitrate Type, Thiamine Hydrochloride Type, Others), By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injectable
Solution), By Dosage Strength (50mg, 100mg, 250mg), By Distribution Channel
(Online v/s Offline), By Application (Beriberi, Wernicke's Encephalopathy
Syndrome, Delirium, Others), By End User (Adult v/s Pediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India vitamin
B1 market and provides statistics & information on market size, structure
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India vitamin B1 market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]